THE PROBLEM. The inability to consistently and affordably produce high-quality advanced therapies limits their global reach. At the bench, generating enough mammalian cells remains the primary constraint, from 3D cell assays to translational research and early-stage bioproduction. The root cause is... Read more
This company has no org chart yet
This company has no teams yet
This company has no offices yet